In October 2025, Sharp announced plans to invest $100 million across its United States and European facilities to expand ...

Despite these pressures, loyalty to the field remains high. Indeed, more than 46% of respondents strongly disagree with leaving the bio/pharma industry entirely, a dip from the 59% who felt this ...

In this PharmTech video feature, we highlight the week’s industry news in an easy-to-consume, fun format. New roundups will ...

Single-use systems streamline CGT manufacturing by reducing cleaning validation and enabling quick changeovers, essential for ...

FDA and EMA have issued 10 guiding principles for AI in drug development with the intended goal of ensuring safety and ...

At Pharmapack Europe 2026, which is being held in Paris on January 21–22, SÜDPACK Medica (Booth 4F12) will showcase a ...

AI and machine learning are revolutionizing drug discovery, development, and lifecycle management, addressing industry ...

AI prioritizes clinical trials by identifying unmet medical needs, optimizing resource allocation, and focusing on conditions ...

Industry anxiety over growth and pricing pressures leads to cautious investment, resulting in slower growth and a ...

Aseptic processing demands reliable, robust, and validated analytical methods to ensure sterility, safety, and quality, ...

Syngene has extended its Bristol Myers Squibb alliance to 2035 and invests in automation to accelerate integrated drug development and manufacturing. Sharp increases European injectable assembly and ...

PharmTech spoke with Dr. Asma Patel, VP Global Commercial and Scientific Consulting–Drug Product, to find out how the growth ...